ArticleClinical ophthalmology (Auckland, N.Z.)2025

Twelve-Month Outcomes of Faricimab for Patients with Sub-Optimally Responsive Diabetic Macular Oedema: A Retrospective Single-Centre Study.

Kamal El-Badawi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.